Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Enanta Pharmaceuticals Inc

+ Add to Watchlist

ENTA:US

36.0400 USD 0.1800 0.50%

As of 20:10:00 ET on 03/03/2015.

Snapshot for Enanta Pharmaceuticals Inc (ENTA)

Open: 35.4900 Day's Range: 34.9500 - 36.4200 Volume: 229,173
Previous Close: 35.8600 52wk Range: 31.2197 - 52.5800 1-Yr Rtn: -7.21%

Stock Chart for ENTA

No chart data available.
  • ENTA:US 36.0400
  • 1D
  • 1M
  • 1Y
35.8600
Interactive ENTA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ENTA

Current P/E Ratio (ttm) 8.5000
Estimated P/E(09/2015) 7.1593
Relative P/E vs. SPX 0.4522
Earnings Per Share (USD) (ttm) 4.2400
Est. EPS (USD) (09/2015) 5.0340
Est. PEG Ratio -
Market Cap (M USD) 673.24
Shares Outstanding (M) 18.68
30 Day Average Volume 386,243
Price/Book (mrq) 3.4630
Price/Sale (ttm) 5.3832
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ENTA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ENTA

Enanta Pharmaceuticals, Inc. manufactures pharmaceutical products. The Company develops, produces, and markets antibacterial drugs for hepatitis C virus, respiratory tract infections, intravenous, and oral treatments for hospitals and communities. Enanta Pharmaceuticals offers its products throughout the United States.

Jay R LulyPresident/CEOPaul J MellettSenior VP:Finance/CFO
Yat Sun OrSenior VP:R&D/CSOTimothy D OcainSenior VP:New Product Strategy
More Company Profile & Key Executives for ENTA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil